TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 MARKET APPLICATION COVERAGE GRID
2.10 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 INDUSTRY INSIGHTS
4.1 REIMBURSEMENT SCENARIO
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING AWARENESS FOR COSMETIC PROCEDURES AMONG PEOPLE
5.1.2 RISING PREVALENCE OF OBESITY
5.1.3 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
5.1.4 INCREASED RELIABILITY ON LIPOSUCTION PROCEDURE
5.1.5 AVAILABILITY OF ADVANCED AND USER FRIENDLY PRODUCTS
5.2 RESTRAINTS
5.2.1 HIGH COST OF PROCEDURES
5.2.2 INCREASED RISKS ASSOCIATED WITH THE PROCEDURES
5.2.3 STRINGENT REGULATIONS FOR APPROVAL OF PRODUCTS
5.3 OPPORTUNITIES
5.3.1 EVOLUTION IN LASER AND RF DEVICES
5.3.2 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR COSMETIC PROCEDURES
5.3.3 INTRODUCTION OF NOVEL NON- INVASIVE TECHNOLOGY
5.4 CHALLENGES
5.4.1 INCREASED RECOVERY TIME OF PROCEDURES
5.4.2 REQUIREMENT OF MULTIPLE SESSIONS FOR GETTING MAXIMUM RESULTS
6 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY TYPE
6.1 OVERVIEW
6.2 MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY
6.2.1 ULTRASOUND
6.2.2 CRYOLIPOLYSIS
6.2.3 RADIOFREQUENCY-ASSISTED CONTOURING
6.2.4 LOW-LEVEL LASERS
6.2.5 COMBINATION TREATMENT
6.2.6 INJECTABLE ADIPOCYTOLYSIS
6.2.7 OTHERS
6.3 INVASIVE METHOD
6.3.1 LIPOSUCTION
6.3.2 SURGICAL REJUVENATION
6.3.3 CHIN IMPLANT
7 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY END USER
7.1 OVERVIEW
7.2 COSMETIC CENTERS
7.3 HOSPITALS
7.4 DERMATOLOGY CLINICS
7.5 MEDICAL SPA
7.6 OTHERS
8 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL
8.1 OVERVIEW
8.2 DIRECT TENDER
8.3 RETAIL SALES
9 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY GEOGRAPHY
9.1 ASIA-PACIFIC
9.1.1 JAPAN
9.1.2 CHINA
9.1.3 AUSTRALIA
9.1.4 SOUTH KOREA
9.1.5 SINGAPORE
9.1.6 INDIA
9.1.7 MALAYSIA
9.1.8 THAILAND
9.1.9 INDONESIA
9.1.10 PHILIPPINES
9.1.11 REST OF ASIA-PACIFIC
10 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11 SWOT & DATA BRIDGE MARKET RESEARCH ANALYSIS
11.1 SWOT ANALYSIS
11.1.1 STRENGTH: - SIGNIFICANT GROWTH OF SHARES IN MARKET FOCUSED SEGMENT
11.1.2 STRENGTH: - FOCUSED ON AESTHETIC SOLUTIONS
11.1.3 WEAKNESS: DEPENDENCE ON SUPPLIERS/ DISTRIBUTORS
11.1.4 OPPORTUNITY: - STRATEGIC INITIATIVES FOR BUSINESS EXPANISION BY PRODUCT LAUNCH, ACQUISITION AND OTHERS
11.1.5 THREAT: - CURRENCY FLUCTUATION
11.2 DATA BRIDGE MARKET RESEARCH ANALYSIS
12 COMPANY PROFILE
12.1 ALLERGAN
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 INMODE
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 HIRONIC CO., LTD.
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 CANDELA CORPORATION
12.4.1 COMPANY SNAPSHOT
12.4.2 COMPANY SHARE ANALYSIS
12.4.3 PRODUCT PORTFOLIO
12.4.4 RECENT DEVELOPMENT
12.5 CYNOSURE LLC
12.5.1 COMPANY SNAPSHOT
12.5.2 PRODUCT PORTFOLIO
12.5.3 RECENT DEVELOPMENTS
12.6 BTL GROUP OF COMPANIES
12.6.1 COMPANY SNAPSHOT
12.6.2 SOLUTION PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
12.7 ALMA LASERS (A SUBSIDIARY OF SISRAM MEDICAL LTD)
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENTS
12.8 ENDYMED MEDICAL
12.8.1 COMPANY SNAPSHOT
12.8.2 REVENUE ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 CUTERA
12.9.1 COMPANY SNAPSHOT
12.9.2 REVENUE ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENT
12.10 ALASTIN SKINCARE, INC.
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENTS
12.11 ERCHONIA CORPORATION
12.11.1 COMPANY SNAPSHOT
12.11.2 PRODUCT PORTFOLIO
12.11.3 RECENT DEVELOPMENT
12.12 LASER LIPO LTD.
12.12.1 COMPANY SNAPSHOT
12.12.2 PRODUCT PORTFOLIO
12.12.3 RECENT DEVELOPMENT
12.13 LUMENIS
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENT
12.14 SOLTA MEDICAL
12.14.1 COMPANY SNAPSHOT
12.14.2 BRAND PORTFOLIO
12.14.3 RECENT DEVELOPMENT
12.15 THERMIGEN, LLC.
12.15.1 COMPANY SNAPSHOT
12.15.2 PRODUCT PORTFOLIO
12.15.3 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 CONCLUSION
15 RELATED REPORTS